These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38324678)

  • 1. Rational design of ICD-inducing nanoparticles for cancer immunotherapy.
    Zhang Z; Pan Z; Li Q; Huang Q; Shi L; Liu Y
    Sci Adv; 2024 Feb; 10(6):eadk0716. PubMed ID: 38324678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer.
    Zhang W; Chen G; Chen Z; Yang X; Zhang B; Wang S; Li Z; Yang Y; Wu Y; Liu Z; Yu Z
    J Control Release; 2024 Jul; 371():470-483. PubMed ID: 38849094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Delivery Nanobooster to Enhance Immunogenic Cell Death for Cancer Chemoimmunotherapy.
    Yan C; Zhao Y; Liu X; Jiang Y; Li Q; Yang L; Li X; Luo K
    ACS Appl Mater Interfaces; 2024 Jul; 16(26):33169-33181. PubMed ID: 38915234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy.
    Feng X; Li F; Zhang L; Liu W; Wang X; Zhu R; Qiao ZA; Yu B; Yu X
    Acta Biomater; 2022 Apr; 143():392-405. PubMed ID: 35259519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic Reticulum-Targeting AIE Photosensitizers to Boost Immunogenic Cell Death for Immunotherapy of Bladder Carcinoma.
    Miao Z; Li J; Zeng S; Lv Y; Jia S; Ding D; Li W; Liu Q
    ACS Appl Mater Interfaces; 2024 Jan; 16(1):245-260. PubMed ID: 38113527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy.
    Dai Z; Wang Q; Tang J; Wu M; Li H; Yang Y; Zhen X; Yu C
    Biomaterials; 2022 Jan; 280():121261. PubMed ID: 34815099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria-associated ER stress evokes immunogenic cell death through the ROS-PERK-eIF2α pathway under PTT/CDT combined therapy.
    Feng X; Lin T; Chen D; Li Z; Yang Q; Tian H; Xiao Y; Lin M; Liang M; Guo W; Zhao P; Guo Z
    Acta Biomater; 2023 Apr; 160():211-224. PubMed ID: 36792045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy.
    Zhao X; Yang K; Zhao R; Ji T; Wang X; Yang X; Zhang Y; Cheng K; Liu S; Hao J; Ren H; Leong KW; Nie G
    Biomaterials; 2016 Sep; 102():187-97. PubMed ID: 27343466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.
    Duan X; Chan C; Lin W
    Angew Chem Int Ed Engl; 2019 Jan; 58(3):670-680. PubMed ID: 30016571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
    Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
    J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy.
    Li W; Jiang Y; Lu J
    Int J Pharm; 2023 Mar; 634():122655. PubMed ID: 36720448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Targeted Nanomedicine for Immunotherapy.
    Cabral H; Kinoh H; Kataoka K
    Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
    Qi J; Jin F; Xu X; Du Y
    Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive Peptide Nanodrugs Based on Supramolecular Assembly for Boosting Immunogenic Cell Death-Induced Cancer Immunotherapy.
    Liu Y; Chang R; Xing R; Yan X
    Small Methods; 2023 May; 7(5):e2201708. PubMed ID: 36720041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-mediated celastrol ER targeting delivery amplify immunogenic cell death in melanoma.
    Wang F; Lai W; Xie D; Zhou M; Wang J; Xu R; Zhang R; Li G
    J Adv Res; 2024 Jun; ():. PubMed ID: 38897272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition.
    Zheng RR; Zhao LP; Huang CY; Cheng H; Yang N; Chen ZX; Cai H; Zhang W; Kong RJ; Li SY
    ACS Nano; 2023 Jun; 17(11):9972-9986. PubMed ID: 37200049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.
    Chen Q; Li C; Wang Q
    Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of ICD via Nanotechnology.
    Qin Y; Zhang H; Li Y; Xie T; Yan S; Wang J; Qu J; Ouyang F; Lv S; Guo Z; Wei H; Yu CY
    Macromol Biosci; 2023 Sep; 23(9):e2300093. PubMed ID: 37114599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.